# Trial With Bronchipret and Sinupret to Evaluate Acceleration of Mucociliary Clearance (MCC)

> **NCT01928901** · PHASE2 · COMPLETED · sponsor: **Bionorica SE** · enrollment: 56 (actual)

## Conditions studied

- Current Smokers

## Interventions

- **DRUG:** administration of Sinupret
- **DRUG:** administration of Bronchipret
- **DRUG:** administration of Sinupret Placebo
- **DRUG:** administration of Bronchipret Placebo

## Key facts

- **NCT ID:** NCT01928901
- **Lead sponsor:** Bionorica SE
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2013-12
- **Final completion:** 2014-02
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2014-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01928901

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01928901, "Trial With Bronchipret and Sinupret to Evaluate Acceleration of Mucociliary Clearance (MCC)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01928901. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*